Literature DB >> 17662939

Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InlB.

Hartmut H Niemann1, Volker Jäger, P Jonathan G Butler, Joop van den Heuvel, Sabine Schmidt, Davide Ferraris, Ermanno Gherardi, Dirk W Heinz.   

Abstract

The tyrosine kinase Met, the product of the c-met proto-oncogene and the receptor for hepatocyte growth factor/scatter factor (HGF/SF), mediates signals critical for cell survival and migration. The human pathogen Listeria monocytogenes exploits Met signaling for invasion of host cells via its surface protein InlB. We present the crystal structure of the complex between a large fragment of the human Met ectodomain and the Met-binding domain of InlB. The concave face of the InlB leucine-rich repeat region interacts tightly with the first immunoglobulin-like domain of the Met stalk, a domain which does not bind HGF/SF. A second contact between InlB and the Met Sema domain locks the otherwise flexible receptor in a rigid, signaling competent conformation. Full Met activation requires the additional C-terminal domains of InlB which induce heparin-mediated receptor clustering and potent signaling. Thus, although it elicits a similar cellular response, InlB is not a structural mimic of HGF/SF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17662939     DOI: 10.1016/j.cell.2007.05.037

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  61 in total

Review 1.  Targeting MET in cancer: rationale and progress.

Authors:  Ermanno Gherardi; Walter Birchmeier; Carmen Birchmeier; George Vande Woude
Journal:  Nat Rev Cancer       Date:  2012-01-24       Impact factor: 60.716

2.  Bayesian Weighing of Electron Cryo-Microscopy Data for Integrative Structural Modeling.

Authors:  Massimiliano Bonomi; Samuel Hanot; Charles H Greenberg; Andrej Sali; Michael Nilges; Michele Vendruscolo; Riccardo Pellarin
Journal:  Structure       Date:  2018-11-01       Impact factor: 5.006

Review 3.  Targeting the HGF/Met signaling pathway in cancer therapy.

Authors:  Fabiola Cecchi; Danie C Rabe; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

Review 4.  Exploitation of the ubiquitin system by invading bacteria.

Authors:  Olivia Steele-Mortimer
Journal:  Traffic       Date:  2010-11-24       Impact factor: 6.215

5.  Structure of an SspH1-PKN1 complex reveals the basis for host substrate recognition and mechanism of activation for a bacterial E3 ubiquitin ligase.

Authors:  Alexander F A Keszei; Xiaojing Tang; Craig McCormick; Elton Zeqiraj; John R Rohde; Mike Tyers; Frank Sicheri
Journal:  Mol Cell Biol       Date:  2013-11-18       Impact factor: 4.272

6.  Quantitative phosphokinome analysis of the Met pathway activated by the invasin internalin B from Listeria monocytogenes.

Authors:  Tobias Reinl; Manfred Nimtz; Claudia Hundertmark; Thorsten Johl; György Kéri; Jürgen Wehland; Henrik Daub; Lothar Jänsch
Journal:  Mol Cell Proteomics       Date:  2009-07-29       Impact factor: 5.911

7.  MET-activating Residues in the B-repeat of the Listeria monocytogenes Invasion Protein InlB.

Authors:  Willem M Bleymüller; Nina Lämmermann; Maria Ebbes; Daniel Maynard; Christina Geerds; Hartmut H Niemann
Journal:  J Biol Chem       Date:  2016-10-27       Impact factor: 5.157

8.  Met receptor tyrosine kinase degradation is altered in response to the leucine-rich repeat of the Listeria invasion protein internalin B.

Authors:  Xiu Gao; Marta Lorinczi; Kristen S Hill; Natasha C Brooks; Hatem Dokainish; Keith Ireton; Lisa A Elferink
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

9.  Listeria monocytogenes internalin B activates junctional endocytosis to accelerate intestinal invasion.

Authors:  Mickey Pentecost; Jyothi Kumaran; Partho Ghosh; Manuel R Amieva
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

10.  Decorin is a novel antagonistic ligand of the Met receptor.

Authors:  Silvia Goldoni; Ashley Humphries; Alexander Nyström; Sampurna Sattar; Rick T Owens; David J McQuillan; Keith Ireton; Renato V Iozzo
Journal:  J Cell Biol       Date:  2009-05-11       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.